| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Research Abstract |
Circulating CD14^+monocytes in rheumatoid arthritis(RA) patients had been already activated, but the number of circulating CD14^+CXCR4^<high> monocytes(Mos) possibly involved in joint repair in RA decreased compared with that in healthy donors. Moreover, the number of circulating CD14^+CXCR4high Mo in RA patients with high disease activity was lower than that in RA patients with low disease activity. On the other hand, CD14^+CD15^+Mos possibly involved in joint destruction abundantly existed in both iliac bone marrow and peripheral blood of RA patients, although CD14^+CD15^+Mos also existed in peripheral blood of healthy donors. These results indicated that the balance of the number of CD14^+CXCR4^<high> Mo and CD14^+CD15^+Mo is important for development of RA.
|
